Nancy Harrison is a nationally recognized life sciences leader with nearly 30 years of experience. She is a Venture Partner at Amplitude Ventures and co-founded MSI Methylation Sciences, where she raised over $70M and advanced its drug to phase II trials. Previously, she was a Senior VP at Ventures West, expanding its Life Sciences portfolio from zero to over 30% and growing assets under management from $90M to $800M.

Nancy serves on boards for companies and non-profits, including Genome BC’s I2 Venture Fund and BioteCanada’s advisory board. With an MBA from McGill and an Engineering degree from Queen’s, she has earned awards, including Life Science BC’s 2020 Milton Wong Leadership Award and the 2020 PEAK Award for Excellence in Leadership.